US FDA approves AbbVie's drug for Parkinson's disease - reuters.com
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
A woman who had a large tumour removed has spoken out about the importance of checking for ovarian cancer symptoms. She …
A faster diagnostic test for brain tumors is now being used in the UK, reducing waiting times from several weeks to just…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →